CDH1 and breast cancer: Cell migration and invasion were reduced by FRK overexpression via inactivation of MAPK, AKT and JAK/STAT pathways and blockade of EMT in breast cancer cells, including inhibition of slug, vimentin, fibronectin, and upregulation of E-cadherin (85).